The Challenge Faced
As with any world-class pharmaceutical manufacturing facility the requirement for state of the art scanning and printing equipment would prove paramount. Secondary to this requirement was a reliable in-country supplier who could advise on the best equipment to allow smooth integration of production, warehouse and back office processes. As well as a focus on actual production facility within the Cork plant there was also a requirement to automate the warehouse facility to accurately monitor and reconcile throughput of in-bound ingredients and out-bound finished products.
After a detailed tender process Centocor identified Peak Technologies as the best fit to advise and supply AutoID materials for the production and warehouse facilities. Having close ties to the worlds leading manufacturers of AutoID equipment and a dedicated in-house Service and Support team Peak Technologies were able to deliver the best solutions for a busy pharmaceutical manufacturing facility.
Handheld Barcode Scanner
Mid-Range Barcode Label Printer
Return On Investment
The Centocor facility at Ringaskiddy now forms the strategic manufacturing centre of a new global supply chain for the company for many of their existing and new pipeline recombinant mammalian cell fermentation and monoclonal antibody products. This new manufacturing unit will produce products for the detection and treatment of many human diseases on a commercial scale but also is used to produce smaller quantities of drug material for clinical trials. The equipment commissioned for this facility will prove key to future growth as well as product integrity and Peak Technologies are proud to be a part of this process.
According to Centocor – “The wireless barcode scanners provided by Peak Technologies work seamlessly with our global SAP environment. We are very pleased with the solution and on going support provided by Peak Technologies and would have no hesitation in recommending them.”
Centocor is a subsidiary of Johnson & Johnson and manufactures active ingredients for medical products at their Cork site in Ringaskiddy. For more than 25 years, Centocor has been a leader in the field of biomedicines. Through the dynamic science of biotechnology, they continue to seek innovative ways to treat cancer, infectious diseases, cardiovascular and metabolic diseases, and immunemediated inflammatory disorders (I.M.I.D.s), such as rheumatoid arthritis and psoriasis. Centocor’s work has revolutionized the science of immunology. They pioneered monoclonal antibody technology, a cutting-edge approach that launched a new generation of products to treat immune-related diseases.
Download the PDF Version
Click the download button below to download the PDF version of this case study to save or share.